Crispr Therapeutics shares tumble after significant earnings miss
Investing.com - Lantheus Holdings Inc (NASDAQ: LNTH) reported third quarter EPS of $1.70, $0.14 better than the analyst estimate of $1.56. Revenue for the quarter came in at $378.73M versus the consensus estimate of $371.81M.
Guidance
Lantheus Holdings Inc sees FY 2024 EPS of $6.65-$6.70 versus the analyst consensus of $6.67.
Lantheus Holdings Inc sees FY 2024 revenue of $1.51B-$1.52B versus the analyst consensus of $1.52B.
Lantheus Holdings Inc's stock price closed at $114.96. It is up 18.11% in the last 3 months and up 76.81% in the last 12 months.
Lantheus Holdings Inc saw 0 positive EPS revisions and 11 negative EPS revisions in the last 90 days. See Lantheus Holdings Inc's stock price’s past reactions to earnings here.
According to InvestingPro, Lantheus Holdings Inc's Financial Health score is "excellent performance".
Check out Lantheus Holdings Inc's recent earnings performance, and Lantheus Holdings Inc's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar